>>Aperçu des publications scientifiques du Prof. Anne DEMULDER

Anne DEMULDER

1: Van Blerk M, Bailleul E, Chatelain B, Demulder A, Devreese K, Douxfils J, Jacquemin M, Jochmans K, Mullier F, Wijns W, China B, Vernelen K, Soumali MR. Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme. Int J Lab Hematol. 2017 Aug;39(4):402-408. doi: 10.1111/ijlh.12640. Epub 2017 Mar 17.
>PubMed

2: Derdabi S, Rozen L, Nagant C, Demulder A. Development and validation of technical assays of von Willebrand disease in routine laboratory. Ann Biol Clin (Paris). 2016 Dec 1;74(6):681-687.
>PubMed

3: Rozen L, Noubouossie D, Dedeken L, Huybrechts S, Lê PQ, Ferster A, Demulder A. Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study. Pediatr Blood Cancer. 2017 Feb;64(2):294-301. doi: 10.1002/pbc.26228. Epub 2016 Sep 8.
>PubMed

4: Willems A, Savan V, Faraoni D, De Ville A, Rozen L, Demulder A, Van der Linden P. Heparin Reversal After Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable? J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1184-9. doi: 10.1053/j.jvca.2016.03.004. Epub 2016 Mar 5.
>PubMed

5: Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, Corazza F. Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients. Am J Clin Pathol. 2016 Jun;145(6):862-70. doi: 10.1093/ajcp/aqw076. Epub 2016 Jun 12.
>PubMed

6: Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. Eur J Anaesthesiol. 2015 Dec;32(12):844-50. doi: 10.1097/EJA.0000000000000316.
>PubMed

7: Faraoni D, Rozen L, Willems A, Torres CS, Pereira LM, Demulder A, Van der Linden P. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease. Blood Coagul Fibrinolysis. 2015 Apr;26(3):290-7. doi: 10.1097/MBC.0000000000000238.
>PubMed

8: Safouris A, Demulder A, Triantafyllou N, Tsivgoulis G. Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient. J Neurol Sci. 2014 Nov 15;346(1-2):366-7. doi: 10.1016/j.jns.2014.09.008. Epub 2014 Sep 16.
>PubMed

9: Van Blerk M, Bailleul E, Chatelain B, Demulder A, Devreese K, Douxfils J, Jochmans K, Mullier F, Wijns W, Soumali MR, Coucke W, Vernelen K, Van de Walle P. Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey. Thromb Haemost. 2015 Jan;113(1):154-64. doi: 10.1160/TH14-02-0161. Epub 2014 Sep 18.
>PubMed

10: Rozen L, Huybrechts S, Dedeken L, Heijmans C, Dessars B, Heimann P, Lambert F, Noubouossie DF, Ferster A, Demulder A. Transient leukemia in a newborn without Down syndrome: case report and review of the literature. Eur J Pediatr. 2014 Dec;173(12):1643-7. doi: 10.1007/s00431-013-2163-8. Epub 2013 Nov 20. Review.
>PubMed

11: Rozen L, Copette F, Noubouossie DF, Demulder A. Evaluation of three APTT reagents in a routine laboratory: toward a compromise. Clin Lab. 2013;59(7-8):921-4.
>PubMed

12: Noubouossie DC, Lê PQ, Rozen L, Ziereisen F, Willems D, Demulder A, Ferster A. Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment. Eur J Haematol. 2013 Jul;91(1):46-54. doi: 10.1111/ejh.12113. Epub 2013 Apr 17.
>PubMed

13: Mesquita M, Demulder A, Nazeri A, Bergmann P. Complete aortoiliac thrombosis in a patient during pretransplant cardiovascular evaluation. Indian J Nephrol. 2012 May;22(3):226-7. doi: 10.4103/0971-4065.98773.
>PubMed

14: Noubouossie D, Valsamis J, Corazza F, Rozen L, Debaugnies F, Demulder A. An automated chemiluminescence immunoassay may detect mostly relevant IgG anticardiolipin antibodies according to revised Sydney criteria. Acta Clin Belg. 2012 May-Jun;67(3):184-9.
>PubMed

15: Noubouossie DC, Lê PQ, Rozen L, Debaugnies F, Ferster A, Demulder A. Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays. Thromb Res. 2012 Aug;130(2):259-64. doi: 10.1016/j.thromres.2011.10.016. Epub 2011 Nov 12.
>PubMed

16: Noubouossie DF, Lê PQ, Corazza F, Debaugnies F, Rozen L, Ferster A, Demulder A. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children. Am J Hematol. 2012 Feb;87(2):145-9. doi: 10.1002/ajh.22206. Epub 2011 Nov 4.
>PubMed

17: Quentin C, Huybrechts S, Rozen L, De Laet C, Demulder A, Ferster A. Vitamin B12 deficiency in a 9-month-old boy. Eur J Pediatr. 2012 Jan;171(1):193-5. doi: 10.1007/s00431-011-1577-4. Epub 2011 Sep 21.
>PubMed

18: Filippin L, Debaugnies F, Noubouossié D, Lê PQ, Ferster A, Demulder A. [Thrombin generation test: establishment of reference values according to age and tissue factor concentration is essential before implementation into the laboratory]. Rev Med Brux. 2011 Mar-Apr;32(2):69-73. French.
>PubMed

19: Mesquita M, Demulder A, Wolff F, Mélot C, Damry N, Dratwa M, Bergmann P. Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. Transplant Proc. 2010 Nov;42(9):3444-9. doi: 10.1016/j.transproceed.2010.09.129.
>PubMed

20: Debaugnies F, Azerad MA, Noubouossié D, Rozen L, Hemker HC, Corazza F, Efira A, Demulder A. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. Thromb Res. 2010 Dec;126(6):531-5. doi: 10.1016/j.thromres.2010.09.002. Epub 2010 Sep 25.
>PubMed

21: Wolff F, Mesquita M, Corazza F, Demulder A, Willems D. False positive carbohydrate-deficient transferrin results in chronic hemodialysis patients related to the analytical methodology. Clin Biochem. 2010 Sep;43(13-14):1148-51. doi: 10.1016/j.clinbiochem.2010.06.003. Epub 2010 Jun 17.
>PubMed

22: Mesquita Mdo C, Sol EB, Malarme M, Noubouossie D, Demulder AC. Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis. Clin Ther. 2009 Nov;31(11):2559-64. doi: 10.1016/j.clinthera.2009.11.006.
>PubMed

23: Mesquita M, Demulder A, Damry N, Mélot C, Wittersheim E, Willems D, Dratwa M, Bergmann P. Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Clin Chem Lab Med. 2009;47(3):339-46. doi: 10.1515/CCLM.2009.075.
>PubMed

24: Theunissen C, Janssens P, Demulder A, Nouboussié D, Van-Esbroeck M, Van-Gompel A, Van-Denende J. Falciparum malaria in patient 9 years after leaving malaria-endemic area. Emerg Infect Dis. 2009 Jan;15(1):115-6. doi: 10.3201/eid1501.080909.
>PubMed

25: Mesquita M, Wittersheim E, Demulder A, Dratwa M, Bergmann P. Bone cytokines and renal osteodystrophy in peritoneal dialysis patients. Adv Perit Dial. 2005;21:181-4.
>PubMed

26: Wittersheim E, Mesquita M, Demulder A, Guns M, Louis O, Melot C, Dratwa M, Bergmann P. OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis. Clin Biochem. 2006 Jun;39(6):617-22. Epub 2006 Mar 10.
>PubMed

27: Demulder A. [Pediatric venous thromboembolism: review of the literature and news]. Rev Med Brux. 2005;26 Spec no:Sp27-30. Review. French.
>PubMed

28: Brachet C, Azzi N, Demulder A, Devalck C, Gourdin A, Gulbis B, Klein A, Le PQ, Loop M, Sariban E, Ferster A. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome. Bone Marrow Transplant. 2004 Apr;33(8):799-803.
>PubMed

29: Loop M, Ferster A, Corazza F, Alhenc-Gelas M, Demulder A. Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency. J Pediatr Hematol Oncol. 2004 Jan;26(1):2-4.
>PubMed

30: Corazza F, Hermans C, Ferster A, Fondu P, Demulder A, Sariban E. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children. Pediatr Res. 2004 Jan;55(1):152-8. Epub 2003 Oct 15.
>PubMed

31: Akopian A, Demulder A, Ouriaghli F, Corazza F, Fondu P, Bergmann P. Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders? Peptides. 2000 Apr;21(4):559-64.
>PubMed

32: Klein A, Corazza F, Demulder A, Van Beers D, Ferster A. Recurrent viral associated hemophagocytic syndrome in a child with Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):554-6.
>PubMed

33: Demulder A, Guns M, Ismail A, Wilmet E, Fondu P, Bergmann P. Increased osteoclast-like cells formation in long-term bone marrow cultures from patients with a spinal cord injury. Calcif Tissue Int. 1998 Nov;63(5):396-400.
>PubMed

34: Demulder A, Fondu P. [Preventive management of patients presenting with an increased tendency to venous thrombosis]. Rev Med Brux. 1997 Jun;18(3):113-8. Review. French.
>PubMed

35: Gourdin A, Demulder A, Ferster A, Fondu P. [Value of in vitro study of osteoclast precursors in the case of severe infantile osteopetrosis treated by bone marrow graft]. Arch Pediatr. 1997 Apr;4(4):335-8. French.
>PubMed

36: Pepersack T, Corazza F, Demulder A, Guns M, Fondu P, Bergmann P. Lithium inhibits calcitriol-stimulated formation of multinucleated cells in human long-term marrow cultures. J Bone Miner Res. 1994 May;9(5):645-50.
>PubMed

37: Putz P, Buyse H, Delvaux D, Kutnowski M, Demulder A, Dumont N, Lavenne E, Claes R, Rosillon D. Triflusal versus acetylsalicylic acid: a double-blind study for the prophylaxis of deep vein thrombosis after hip surgery. Acta Chir Belg. 1991 Nov-Dec;91(6):269-76.
>PubMed

!Données extraites de PubMed et filtrées pour limiter les risques d'homonymie. Vous pouvez supprimer le filtre "Brugmann" afin d'élargir les résultats.

>>Consulter la fiche d'identité du Prof. Anne DEMULDER.